Detalhe da pesquisa
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763153
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763154
3.
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
N Engl J Med
; 386(12): 1132-1142, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179323
4.
Other-cause mortality in incidental prostate cancer.
Prostate
; 84(8): 731-737, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506561
5.
Charles Brenton Huggins: A historical review of the Nobel laureate's pioneering discoveries.
Cancer
; 130(7): 1019-1024, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146679
6.
Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE).
Cancer
; 130(11): 1930-1939, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340349
7.
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
Br J Cancer
; 130(1): 73-81, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951974
8.
Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.
Oncologist
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527096
9.
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.
Oncologist
; 29(3): 235-243, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37812679
10.
Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement.
Ann Surg Oncol
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526833
11.
Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma.
Ann Surg Oncol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773038
12.
Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer.
BJU Int
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494989
13.
Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
World J Urol
; 42(1): 269, 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679642
14.
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients.
World J Urol
; 42(1): 343, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775841
15.
Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy.
World J Urol
; 42(1): 193, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530480
16.
Contemporary conditional cancer-specific survival rates in surgically treated nonmetastatic primary urethral carcinoma.
J Surg Oncol
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606531
17.
Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients.
J Surg Oncol
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470523
18.
TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer.
Future Oncol
; 20(9): 493-505, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882449
19.
A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer.
Jpn J Clin Oncol
; 54(5): 592-598, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369557
20.
The effect of married status on cancer-specific mortality in nonmetastatic pelvic liposarcoma patients according to sex.
World J Surg
; 48(1): 97-103, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686806